Cardiopulmonary effects of antimalarial drugs. 3. Diaminopyrimidines: trimethoprim (WR 5949) and 5-piperonyl-2,4-diaminopyrimidine (WR 40,070).
D000200:Action Potentials / Q000187:drug effects; D000813:Anilides / Q000494:pharmacology; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002725:Chloroform / Q000494:pharmacology; D004562:Electrocardiography; D005112:Extracorporeal Circulation; D005492:Folic Acid / Q000494:pharmacology; D005493:Folic Acid Antagonists / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D006352:Heart Ventricles / Q000187:drug effects; D008564:Membrane Potentials; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000032:analysis; D009638:Norepinephrine / Q000494:pharmacology; D010961:Plasmodium; D011739:Pyrimethamine / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013451:Sulfonic Acids / Q000494:pharmacology
D000813:Anilides; D000962:Antimalarials; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013451:Sulfonic Acids; D002725:Chloroform; D012110:Reserpine; D005492:Folic Acid; D009638:Norepinephrine; D011739:Pyrimethamine